Search

everythinglearnresearchcommunity

for

Search:↓

ALDOA levels drop in hair cells during hair loss.

SLE and DM can coexist but are rare and need careful evaluation.

People with Down syndrome have a higher risk of skin disorders and need better screening and treatment.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Prolactin may be important for skin growth and immune function.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

IGF-1 affects hair loss and could be a potential treatment.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Effective treatments for severe alopecia areata are still lacking.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Permanent hair dye may cause total hair loss.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Leflunomide is more likely to help treat alopecia areata than cause it.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.